ClinVar Miner

Submissions for variant NM_000169.3(GLA):c.902G>C (p.Arg301Pro)

dbSNP: rs104894828
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001958657 SCV002235156 pathogenic Fabry disease 2021-05-19 criteria provided, single submitter clinical testing This sequence change replaces arginine with proline at codon 301 of the GLA protein (p.Arg301Pro). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and proline. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg301 amino acid residue in GLA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12175777, 23935525, 27657681, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this variant affects GLA protein function (PMID: 22004918, 23935525). This variant has been observed in individual(s) with Fabry disease (PMID: 11322659, 27834756, 15702404, Invitae).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.